ANIKA THERAPEUTICS
Anika Therapeutics, Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. We partner with physicians to understand what they need most in order to treat their patients and we develop minimally invasive products that restore active living for people around the world. We are committed to leading in high opportunity spaces within orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair and bone preserving joint technologies. Anika. Restore Active Living.™
ANIKA THERAPEUTICS
Industry:
Biotechnology Health Care Manufacturing Therapeutics
Founded:
1992-01-01
Address:
Bedford, Massachusetts, United States
Country:
United States
Website Url:
http://www.anikatherapeutics.com
Total Employee:
251+
Status:
Active
Contact:
781-457-9000
Email Addresses:
[email protected]
Technology used in webpage:
Domain Not Resolving IPv6 ReCAPTCHA Cloudflare Hosting Google Google Cloud Contact Form 7 WordPress 6.4 YouTube ReCAPTCHA V2
Similar Organizations
Aceto
Aceto is a global virtual manufacturer supplying niche, differentiated specialty materials in life sciences and advanced technology.
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Angus Chemical
Angus Chemical specialty and fine chemical company dedicated to the development of novel chemistries.
ATCC
ATCC global biological materials resource and standards organization.
Beckman Coulter
Beckman Coulter develops, manufactures and markets products that simplify & automate biomedical testing for lab professionals.
BioVectra
BioVectra offers contract development and manufacturing capacity for intermediates and active pharmaceutical ingredients.
FMC Corporation
FMC Corporation is an US-based chemical manufacturing company producing solutions for the agricultural, textile, and healthcare industries.
Hach
Hach Company manufactures and distributes analytical instruments and reagents used to test the quality of water and other liquid solutions.
Lannett Company
Lannett develops, manufactures, and distributes generic prescription pharmaceutical products in tablet.
Nephron Pharmaceuticals
Nephron Pharmaceuticals Corporation is a mid-sized company that manufactures generic respiratory medications.
Current Advisors List
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-01-06 | Parcus Medical | Parcus Medical acquired by Anika Therapeutics | 35 M USD |
| 2020-01-06 | Arthrosurface | Arthrosurface acquired by Anika Therapeutics | 60 M USD |
| 2009-12-31 | Fidia Farmaceutici | Fidia Farmaceutici acquired by Anika Therapeutics | N/A |
Investors List
Caligan Partners
Caligan Partners investment in Post-IPO Equity - Anika Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2024-05-08 | Anika Therapeutics appoints Steve Griffin as finance chief |
| 2020-02-13 | Anika Therapeutics Appoints Cheryl Blanchard Interim CEO |
Official Site Inspections
http://www.anikatherapeutics.com
- Host name: 38.254.231.35.bc.googleusercontent.com
- IP address: 35.231.254.38
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Anika Therapeutics"
Therapeutic Product Innovation & Performance - Anika …
Anika is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. We partner with clinicians to understand what they need most to treat their patients and we develop …See details»
Anika Investor Relations - Overview
Primary IR Contact. Matt Hall. Director, Corporate Development and Investor Relations. Anika Therapeutics, Inc. Phone: (781) 457-9554. Email: [email protected] Transfer AgentSee details»
Anika Therapeutics - Crunchbase Company Profile & Funding
Anika Therapeutics, Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic …See details»
Anika - LinkedIn
Anika | 22,030 followers on LinkedIn. Anika. Restore Active Living.® | Anika is a global joint preservation company that creates and delivers meaningful advancements in early intervention ...See details»
Anika Therapeutics, Inc. (ANIK) Company Profile & Overview
Apr 29, 1993 Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain …See details»
Anika Investor Relations - Annual Reports and Proxies
Anika Therapeutics 2017 Annual Report. Anika Therapeutics 2016 Annual Report. Anika Therapeutics 2015 Annual Report. Proxy Statements. Anika Therapeutics 2024 Proxy Statement. Anika Therapeutics 2023 Proxy …See details»
Anika Therapeutics - Overview, News & Similar companies
Jun 3, 2024 Anika to Issue Second Quarter 2024 Financial Results on Thursday, August 8, 2024 BEDFORD, Mass., July 25, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. …See details»
Anika Therapeutics Company Profile - Office Locations ... - Craft
Oct 29, 2024 Anika Therapeutics has 5 employees across 4 locations and $166.66 m in annual revenue in FY 2023. See insights on Anika Therapeutics including office locations, …See details»
History - Anika Therapeutics
FDA 510(k) clearance received and first surgeries performed with the X-Twist Fixation System, a highly versatile suture anchor system, and a cornerstone product for Anika’s sports medicine …See details»
Anika Investor Relations - News Releases
BEDFORD, Mass., March 6, 2023 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results for its …See details»
Careers - Anika Therapeutics
Our Statement on Equal Employment Opportunity. Anika believes in equal employment opportunities for all employees and job applicants. Our organization’s success depends on the …See details»
News Releases - Anika Investor Relations
BEDFORD, Mass., October 4 , 2024 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on October 1, …See details»
Anika To Launch Six FDA-Cleared Sports Medicine and
Jul 20, 2020 Anika Therapeutics, Inc. Sylvia Cheung, 781-457-9000 Chief Financial Officer [email protected] ...See details»
Anika Announces First Surgeries Performed using the Integrity™ …
Nov 28, 2023 Integrity marks Anika’s entrance into the fast-growing $150 million+2 U.S. rotator cuff augmentation market and expansion of its proprietary hyaluronic acid (HA) regenerative …See details»
Anika Investor Relations - News Releases
BEDFORD, Mass., November 8, 2022 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results for its …See details»
Patient Solutions And Resources - Anika Therapeutics
Anika offers a range of minimally invasive joint preservation products. Learn about solutions that are helping restore active living for people around the world.See details»
The Improbable Transformation of Anika Therapeutics
Dec 6, 2021 For 2021, Wall Street analysts are forecasting that Anika Therapeutics will report around $150 million in sales and about $3.75 million in earnings. However, the income …See details»
Anika Investor Relations - ESG
Environmental Performance and Goals. In 2023, Anika committed to evaluate ways to reduce its carbon footprint in its contribution to the Paris Climate agreement which seeks to limit global …See details»
Anika Investor Relations - News Releases
Sep 1, 2021 Anika Therapeutics, Inc. Mark Namaroff, 781-457-9287 Executive Director, Investor Relations and Corporate Communications [email protected] . For Media Inquiries: …See details»